ClinicalTrials.Veeva

Menu
M

Multiprofile Hospital for Active Treatment Sveta Sofia | Internal Diseases Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Neladenoson Bialanate
Aflibercept
Finerenone
Apixaban

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 5 total trials
Status recently updated

A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion) (QUASAR)

Researchers are looking for a better way to treat people who have macular edema secondary to retinal vein occlusion (RVO).In people with RVO, a blood...

Enrolling
Active, not recruiting
Macular Edema Secondary to Retinal Vein Occlusion
Drug: Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_2 mg
Drug: Sham

Trial sponsors

Bayer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems